Cite
HARVARD Citation
Raal, F. et al. (2016). Cardiovascular event rates in homozygous familial hypercholesterolemia (HoFH): Trial assessing long-term use of PCSK9 inhibition in subjects with genetic LDL disorders (TAUSSIG) study interim results. Atherosclerosis. pp. e232-. [Online].